Skip to main content
Premium Trial:

Request an Annual Quote

Jimmy Lin

Natera has appointed Jimmy Lin as chief scientific officer for oncology. Lin most recently led the clinical genomics program at the National Cancer Institute at the National Institutes of Health. Previously, he led the computational analysis of the first ever exome sequencing studies in cancer at Johns Hopkins. Additionally, Lin is the founder and president of the Rare Genomics Institute. 

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.